Elkfork Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$52.4M Sell
248,080
-1,568
-0.6% -$328K 1.28% 13
2019
Q2
$48.5M Buy
249,648
+20,132
+9% +$3.71M 1.18% 15
2019
Q1
$37.8M Buy
229,516
+11,116
+5% +$1.97M 0.95% 21
2018
Q4
$41.1M Sell
218,400
-11,760
-5% -$2.17M 1.16% 16
2018
Q3
$39.2M Buy
230,160
+5,404
+2% +$910K 0.93% 20
2018
Q2
$36.8M Buy
224,756
+2,324
+1% +$380K 0.95% 19
2018
Q1
$36M Sell
222,432
-19,068
-8% -$3.04M 0.97% 21
2017
Q4
$35.3M Sell
241,500
-14,840
-6% -$2.11M 0.96% 21
2017
Q3
$34.8M Sell
256,340
-11,116
-4% -$1.4M 1.01% 21
2017
Q2
$33.5M Sell
267,456
-8,512
-3% -$1.02M 1.01% 21
2017
Q1
$32.8M Sell
275,968
-12,880
-4% -$1.55M 1.01% 23
2016
Q4
$33.3M Buy
+288,848
New +$32.1M 1.1% 20

Other funds holding CME

Elkfork Partners's CME Position: Q3 2019 in Review

Elkfork Partners reduced its CME Group (CME) stake by 0.63% in Q3 2019, selling an estimated $328K and leaving 248,080 shares worth $52.4M. The position accounts for 1.28% of the portfolio, ranked #13.

Elkfork Partners first reported a position in CME in Q4 2016 and has held it in 12 quarters since. 992 funds tracked by Wall St. Rank hold CME as of Q3 2019.

  • Elkfork Partners held 248,080 shares of CME Group worth $52.4M as of Q3 2019.
  • Elkfork Partners sold 1,568 CME Group shares in Q3 2019, an estimated $328K.
  • CME Group made up 1.28% of Elkfork Partners's portfolio in Q3 2019, its #13 holding.
  • Elkfork Partners first reported a position in CME Group in Q4 2016 and has held it in 12 quarters since.
  • 992 funds tracked by Wall St. Rank held CME Group as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.